Breaking barriers: advancing cellular therapies in autoimmune disease management
Autoimmune diseases occur due to a dysregulation within the immune system, leading to an aberrant assault on the organism’s own tissues. The pathogenesis of these conditions is multifactorial, encompassing intricate interplays among genetic predispositions, environmental determinants, and hormonal f...
Saved in:
| Main Authors: | Yanhong Fu, Chunjing Feng, Shan Qin, Zhiyao Xing, Chong Liu, Zichuan Liu, Hongjian Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1503099/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of αCD4 antibody and retinal antigen injection induces long-term disease control in autoimmune uveitis
by: Dijie Qiao, et al.
Published: (2025-08-01) -
Tissue-specific roles of regulatory T cells: mechanisms of suppression and beyond along with emerging therapeutic insights in autoimmune indications
by: Bat-Erdene Jugder, et al.
Published: (2025-08-01) -
Advance in chimeric antigen receptor T therapy in autoimmune diseases
by: Xiaolan Ji, et al.
Published: (2025-03-01) -
Transcriptional fingerprinting of regulatory T cells: ensuring quality in cell therapy applications
by: Zhang Cheng, et al.
Published: (2025-06-01) -
ROS-dependent SOCS3 upregulation disrupts regulatory T cell stability during autoimmune disease development
by: Hiroki Satooka, et al.
Published: (2025-05-01)